Abstract:This review delves into the modulation of fundamental catalytic reactions, a cornerstone in addressing disease treatment through an interdisciplinary lens. Central to this review's discussion is the regulation of chemical reactions while concurrently accounting for the complex microenvironments of diseases to achieve specificity, efficiency, and control of in situ chemical reactions. It seeks to clarify the mechanisms underpinning catalytic biomaterials activated in situ chemical reactions and evaluate their potential to revolutionize treatment strategies across various pathological conditions. Chemical reactions underpin biological processes, and imbalances in critical biochemical pathways within organisms can lead to the onset of severe diseases. Within this context, the emerging field of "Nanocatalytic Medicine" leverages nanomaterials as catalysts to modulate fundamental chemical reactions specific to the microenvironments of diseases. This approach is designed to facilitate the targeted synthesis and localized accumulation of therapeutic agents, thus enhancing treatment efficacy and precision while simultaneously reducing systemic side effects. The effectiveness of these nanocatalytic strategies critically hinges on a profound understanding of chemical kinetics and the intricate interplay of reactions within particular pathological microenvironments to ensure targeted and effective catalytic actions. This review methodically explores in situ catalytic reactions and their associated biomaterials, emphasizing regulatory strategies that control therapeutic responses. Furthermore, the discussion encapsulates the crucial elements‐reactants, catalysts, and reaction conditions/environments‐necessary for optimizing the thermodynamics and kinetics of these reactions, while rigorously addressing both the biochemical and biophysical dimensions of the disease microenvironments to enhance therapeutic outcomes. It seeks to clarify the mechanisms underpinning catalytic biomaterials and evaluate their potential to revolutionize treatment strategies across various pathological conditions.

Diagnostic Imaging and Therapeutic Effects of Nanocatalysts by Intracellular in situ Catalytic Reactions

Diagnostic Imaging and Therapeutic Effects of Nanocatalysts by Intracellular <i>in situ</i> Catalytic Reactions

Exogenous/endogenous stimuli-responsive nanocatalysts trigger in situ chemical reactions for tumor catalytic therapy: an up-to-date mini-review

Back Cover: Nanomaterials for Cascade Promoted Catalytic Cancer Therapy (view 6/2021)

Nanocatalytic Tumor Therapy by Biomimetic Dual Inorganic Nanozyme-Catalyzed Cascade Reaction

The rational design of nanozymes for imaging-monitored cancer therapy

Nanozymes in Catalytic Cancer Theranostics

Nanoreactor-based catalytic systems for therapeutic applications: Principles, strategies, and challenges

Catalytic imaging-guided cancer therapy using non-coordinated and coordinated nanozymes

Nanocatalysts for modulating antitumor immunity: fabrication, mechanisms and applications

Inorganic Nanozymes: Prospects for Disease Treatments and Detection Applications

Catalytic Biomaterials‐Activated In Situ Chemical Reactions: Strategic Modulation and Enhanced Disease Treatment

Nanocatalysis Meets Microfluidics: A Powerful Platform for Sensitive Bioanalysis

Engineering a Self-Fueling and Self-Reported Theranostic Nanocatalyst for Amplified Cancer Imaging and Chemodynamic Therapy

Novel Strategy for Optimized Nanocatalytic Tumor Therapy: From an Updated View

Nanoparticle-triggered in situ catalytic chemical reactions for tumour-specific therapy.

Nanocatalyst‐Mediated Chemodynamic Tumor Therapy

Recent Advances in Cell Imaging and Cytotoxicity of Intracellular Stimuli-Responsive Nanomaterials

Nanocatalytic Anti‐Tumor Immune Regulation

Single‐Atom Catalysts for Nanocatalytic Tumor Therapy

Smart Biomimetic Nanozymes for Precise Molecular Imaging: Application and Challenges